3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
7
Sarcoma, Alveolar Soft Part
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Neoplasms
1
Exanthema
1
Diarrhea
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Chondrosarcoma
1
Interventions
Fluorouracil
8
Bevacizumab
8
Oxaliplatin
7
Leucovorin
7
Irinotecan
7
Capecitabine
7
Cetuximab
6
Panitumumab
4
sintilimab
2
regorafenib
2
aflibercept
2
tremelimumab
1
spartalizumab
1
pembrolizumab
1
irinotecan sucrosofate
1
durvalumab
1
camrelizumab
1
atezolizumab
1
anisodamine
1
SHR-1701
1
Radiotherapy
1
Pemetrexed
1
Nivolumab
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methotrexate
1
Lycopene
1
Loperamide
1
Ipilimumab
1
HMPL-013
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Colorectal Cancer Metastatic
×
Loperamide
×
Clear all
NCT03705442
2018-10-15
Probat-tmcc-17
University Hospital Rijeka
Phase 2
Unknown
76 enrolled